Bay 59-3074

CAS No. 406205-74-1

Bay 59-3074 ( Bay59-3074;Bay-59-3074 )

Catalog No. M14399 CAS No. 406205-74-1

A potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 110 In Stock
50MG 178 In Stock
100MG 332 In Stock
200MG 494 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bay 59-3074
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively.
  • Description
    A potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively; displays antihyperalgesic and antiallodynic effects against thermal or mechanical stimuli in rat models of chronic neuropathic; orally acitve.
  • Synonyms
    Bay59-3074;Bay-59-3074
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1;CB2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    406205-74-1
  • Formula Weight
    453.36
  • Molecular Formula
    C18H13F6NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 34 mg/mL
  • SMILES
    O=S(CCCC(F)(F)F)(OC1=CC=CC(OC2=CC=CC(C(F)(F)F)=C2C#N)=C1)=O
  • Chemical Name
    1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. De Vry J, et al. J Pharmacol Exp Ther. 2004 Aug;310(2):620-32.
2. De Vry J, et al. Eur J Pharmacol. 2004 Nov 28;505(1-3):127-33.
3. Teng H, et al. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5999-6002.
molnova catalog
related products
  • OMDM-5

    OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).

  • CB1 antagonist 2

    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.

  • GAT-100

    GAT-100 (GAT100) is a potent, selective CB1R negative allosteric modulator (NAM) with cAMP EC50 and β-arr EC50 of 174 nM and 2.1 nM.